K-numberK243456
Device nameONVOY™ Acetabular System
ApplicantGlobus Medical, Inc.
Product codeLPH
Device classClass II
Decision dateJun 6, 2025
DecisionSubstantially Equivalent
Regulation888.3358
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ONVOY Acetabular System is a hip prosthesis component used to reconstruct the hip socket (acetabular portion) in patients with severe hip disease or pain from osteoarthritis, rheumatoid arthritis, fractures, or failed previous hip replacements. It consists of acetabular shells, liners, dual mobility components, and femoral heads available in various sizes and configurations for cementless fixation.

Technological characteristics

The ONVOY shells are additively manufactured from titanium alloy powder (differing from predicate manufacturing methods), while liners and dual mobility bearings are made from highly crosslinked UHMWPE with Vitamin E, and dual mobility liners from cobalt-chrome alloy. Key similarities to predicates include design features (locking mechanism, material thickness, bearing diameter), intended use, function, and available size ranges, though the subject devices differ in shell manufacturing method and polyethylene crosslinking radiation dose.

Test standards cited

Testing performed per ASTM F3090, ASTM F1820, ASTM F1875, ASTM F2345, ASTM F2582, ISO 7206-12, ISO 14242, ISO 21535, and ANSI/AAMI ST72:2011, covering mechanical testing (fatigue, disassembly, wear, impingement, fretting and corrosion), range of motion assessment, and bacterial endotoxin testing.

Substantial equivalence argument

The subject ONVOY implants demonstrate substantial equivalence because they maintain the same technological characteristics, function, and indications for use as predicate devices despite differences in manufacturing method (additive manufacturing for shells) and crosslinking radiation dose. Performance data from comprehensive mechanical and biocompatibility testing show these manufacturing differences do not raise new safety or effectiveness concerns, and the devices achieve equivalent performance outcomes to predicate devices across all evaluated parameters.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →